Fibroline signed a new license in the Medical field with NOBAMED

18 . 01 . 2018

The Medical field has been identified by Fibroline as one of the most promising sector for the use of its technologies in the coming years.

Following the first introduction of its technology portfolio to this market during MEDICA 2016, Fibroline dedicated strong R&D efforts to adapt its solutions and penetrate this market.

Fibroline is proud to announce that it has now signed a license together with NOBAMED Paul Danz AG, for the impregnation of woven gauzes.

Several other developments are currently on the go or in negotiation step, confirming the high potential of the Fibroline solutions for the Medical business.

Website :

All news

Also discover